account38 products across Europe, Canada, Australia, New Zealand, Japan and Korea. Strides also has an outlicensing deal with GlaxoSmithKline to supply products for 95 emerging markets and the total market value for products under Strides' various partnerships...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Strides Arcolab's oncology unit gets US FDA nod
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account